These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 23246118

  • 1. A novel cyclosporine a drug-delivery system for prevention of human corneal rejection after high-risk keratoplasty: a clinical study.
    Shi W, Chen M, Xie L, Liu M, Gao H, Wang T, Wu X, Zhao J.
    Ophthalmology; 2013 Apr; 120(4):695-702. PubMed ID: 23246118
    [Abstract] [Full Text] [Related]

  • 2. [Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant].
    Shi W, Xie L, Wang S.
    Zhonghua Yan Ke Za Zhi; 2002 Aug; 38(8):502-5. PubMed ID: 12410993
    [Abstract] [Full Text] [Related]

  • 3. Cyclosporine a drug-delivery system for high-risk penetrating keratoplasty: Stabilizing the intraocular immune microenvironment.
    Zhang T, Li Z, Liu T, Li S, Gao H, Wei C, Shi W.
    PLoS One; 2018 Aug; 13(5):e0196571. PubMed ID: 29734357
    [Abstract] [Full Text] [Related]

  • 4. Experimental study on the effect of cyclosporine A drug delivery system implanted in anterior chamber on high-risk corneal graft rejection.
    Xie L, Shi W, Wang Z, Liu Z.
    Zhonghua Yan Ke Za Zhi; 2002 Jul; 38(7):422-5. PubMed ID: 12411004
    [Abstract] [Full Text] [Related]

  • 5. [Sustained rapamycin drug delivery system in prevention of high risk corneal allograft rejection and neovascularization in rabbits].
    Gao H, Shi WY, Xie LX, Wang SG.
    Zhonghua Yan Ke Za Zhi; 2006 Jan; 42(1):6-11. PubMed ID: 16638273
    [Abstract] [Full Text] [Related]

  • 6. Predicted long-term outcome of corneal transplantation.
    Borderie VM, Boëlle PY, Touzeau O, Allouch C, Boutboul S, Laroche L.
    Ophthalmology; 2009 Dec; 116(12):2354-60. PubMed ID: 19815285
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ten-year postoperative results of penetrating keratoplasty.
    Ing JJ, Ing HH, Nelson LR, Hodge DO, Bourne WM.
    Ophthalmology; 1998 Oct; 105(10):1855-65. PubMed ID: 9787355
    [Abstract] [Full Text] [Related]

  • 9. Deep anterior lamellar keratoplasty using acellular corneal tissue for prevention of allograft rejection in high-risk corneas.
    Li J, Yu L, Deng Z, Wang L, Sun L, Ma H, Chen W.
    Am J Ophthalmol; 2011 Nov; 152(5):762-70.e3. PubMed ID: 21803324
    [Abstract] [Full Text] [Related]

  • 10. Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits.
    Shi W, Gao H, Xie L, Wang S.
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3339-44. PubMed ID: 16877400
    [Abstract] [Full Text] [Related]

  • 11. Graft rejection after Descemet's stripping automated endothelial keratoplasty: graft survival and endothelial cell loss.
    Li JY, Terry MA, Goshe J, Shamie N, Davis-Boozer D.
    Ophthalmology; 2012 Jan; 119(1):90-4. PubMed ID: 22115709
    [Abstract] [Full Text] [Related]

  • 12. Large-diameter penetrating keratoplasty: indications and outcomes.
    Skeens HM, Holland EJ.
    Cornea; 2010 Mar; 29(3):296-301. PubMed ID: 20118782
    [Abstract] [Full Text] [Related]

  • 13. Cyclosporine a drug-delivery system for high-risk keratoplasty.
    Hong J, Liu Z, Sun X, Xu J.
    Ophthalmology; 2013 Sep; 120(9):e65-6. PubMed ID: 24001545
    [No Abstract] [Full Text] [Related]

  • 14. Initial endothelial cell density and chronic endothelial cell loss rate in corneal transplants with late endothelial failure.
    Nishimura JK, Hodge DO, Bourne WM.
    Ophthalmology; 1999 Oct; 106(10):1962-5. PubMed ID: 10519593
    [Abstract] [Full Text] [Related]

  • 15. Intracameral cyclosporine drug delivery system in high-risk keratoplasty.
    Galvis V, Tello A, Carreño NI, Revelo ML.
    Ophthalmology; 2013 Sep; 120(9):e64-5. PubMed ID: 24001543
    [No Abstract] [Full Text] [Related]

  • 16. Risk factors for corneal allograft rejection: intermediate results of a prospective normal-risk keratoplasty study.
    Küchle M, Cursiefen C, Nguyen NX, Langenbucher A, Seitz B, Wenkel H, Martus P, Naumann GO.
    Graefes Arch Clin Exp Ophthalmol; 2002 Jul; 240(7):580-4. PubMed ID: 12136292
    [Abstract] [Full Text] [Related]

  • 17. [Implantation of FK506 drug delivery system into the anterior chamber for inhibiting corneal rejection in high risk rabbit corneal allograft].
    Shi WY, Liu T, Xie LX, Wang SG.
    Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):299-304. PubMed ID: 16762204
    [Abstract] [Full Text] [Related]

  • 18. Long-term changes in corneal endothelial cell density after repeat penetrating keratoplasty in eyes with endothelial decompensation.
    Hayashi K, Kondo H, Maeno A, Takimoto M.
    Cornea; 2013 Jul; 32(7):1019-25. PubMed ID: 23328699
    [Abstract] [Full Text] [Related]

  • 19. Comparison of penetrating keratoplasty and deep lamellar keratoplasty for macular corneal dystrophy and risk factors of recurrence.
    Cheng J, Qi X, Zhao J, Zhai H, Xie L.
    Ophthalmology; 2013 Jan; 120(1):34-9. PubMed ID: 23017278
    [Abstract] [Full Text] [Related]

  • 20. [Regression analysis of corneal endothelium after nonmechanical penetrating keratoplasty].
    Langenbucher A, Nguyen NX, Kus MM, Blüthner K, Küchle M, Seitz B.
    Klin Monbl Augenheilkd; 2000 Jun; 216(6):393-9; discussion 400. PubMed ID: 10919119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.